These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30412063)

  • 1. Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function.
    Becher T; Eder F; Baumann S; Loßnitzer D; Pollmann B; Behnes M; Borggrefe M; Akin I
    Medicine (Baltimore); 2018 Oct; 97(43):e12665. PubMed ID: 30412063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamics and its predictors during Impella-protected PCI in high risk patients with reduced ejection fraction.
    Russo G; Burzotta F; D'Amario D; Ribichini F; Piccoli A; Paraggio L; Previ L; Pesarini G; Porto I; Leone AM; Niccoli G; Aurigemma C; Verdirosi D; Trani C; Crea F
    Int J Cardiol; 2019 Jan; 274():221-225. PubMed ID: 30057165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of peri and post-procedural complications in patients undergoing revascularisation of coronary artery multivessel disease by coronary artery bypass grafting or protected percutaneous coronary intervention with the Impella 2.5 device.
    Becher T; Baumann S; Eder F; Perschka S; Loßnitzer D; Fastner C; Behnes M; Doesch C; Borggrefe M; Akin I
    Eur Heart J Acute Cardiovasc Care; 2019 Jun; 8(4):360-368. PubMed ID: 28660768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six months follow-up of protected high-risk percutaneous coronary intervention with the microaxial Impella pump: results from the German Impella registry.
    Baumann S; Werner N; Al-Rashid F; Schäfer A; Bauer T; Sotoudeh R; Bojara W; Shamekhi J; Sinning JM; Becher T; Eder F; Akin I
    Coron Artery Dis; 2020 May; 31(3):237-242. PubMed ID: 31658135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft in Aged Patients With Unprotected Left Main Artery Lesions.
    Wei Z; Xie J; Wang K; Kang L; Dai Q; Bai J; Xu B
    Int Heart J; 2016 Dec; 57(6):682-688. PubMed ID: 27829638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of five-year outcomes of coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular ejection fractions≤50% versus >50% (from the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Oct; 114(7):988-96. PubMed ID: 25124184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of left ventricular ejection fraction on outcomes after left main revascularization: g-LM Registry.
    Daoulah A; Naser MJ; Hersi AS; Alshehri M; Garni TA; Abuelatta R; Yousif N; Almahmeed W; Alasmari A; Aljohar A; Alzahrani B; Abumelha BK; Ghani MA; Amin H; Hashmani S; Hiremath N; Kazim HM; Refaat W; Selim E; Jamjoom A; El-Sayed O; Al-Faifi SM; Feteih MN; Dahdouh Z; Aithal J; Ibrahim AM; Elganady A; Qutub MA; Alama MN; Abohasan A; Hassan T; Balghith M; Hussien AF; Abdulhabeeb IAM; Ahmad O; Ramadan M; Alqahtani AH; Alshahrani SS; Qenawi W; Shawky A; Ghonim AA; Elmahrouk A; Alhamid S; Maghrabi M; Haddara MM; Iskandar M; Shawky AM; Hurley WT; Elmahrouk Y; Ahmed WA; Lotfi A
    J Cardiovasc Med (Hagerstown); 2023 Jan; 24(1):23-35. PubMed ID: 36219153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Routine angiographic follow-up versus clinical follow-up in patients with multivessel coronary artery diseases following percutaneous coronary intervention with drug-eluting stents: a nested case-control study within a Korean population.
    Kim YH; Her AY; Rha SW; Choi BG; Shim M; Choi SY; Byun JK; Li H; Kim W; Kang JH; Choi JY; Park EJ; Park SH; Lee S; Na JO; Choi CU; Lim HE; Kim EJ; Park CG; Seo HS; Oh DJ
    Coron Artery Dis; 2017 Jun; 28(4):307-314. PubMed ID: 28272162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous coronary intervention in patients with stable coronary artery disease and left ventricular systolic dysfunction: insights from the VA CART program.
    Brophy TJ; Warsavage TJ; Hebbe AL; Plomondon ME; Waldo SW; Rao SV; DeVore AD; Gutierrez JA; Swaminathan RV
    Am Heart J; 2021 May; 235():149-157. PubMed ID: 33567318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiarterial grafts improve the rate of early major adverse cardiac and cerebrovascular events in patients undergoing coronary revascularization: analysis of 12 615 patients with multivessel disease.
    Locker C; Schaff HV; Daly RC; Bell MR; Frye RL; Stulak JM; Said SM; Dearani JA; Joyce LD; Greason KL; Pochettino A; Li Z; Lennon RJ; Lerman A
    Eur J Cardiothorac Surg; 2017 Oct; 52(4):746-752. PubMed ID: 28595326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraising the impact of left ventricular ejection fraction on outcomes of percutaneous drug-eluting stenting for unprotected left main disease: insights from a multicenter registry of 975 patients.
    Biondi-Zoccai G; Sheiban I; Moretti C; Palmerini T; Marzocchi A; Capodanno D; Tamburino C; Margheri M; Vecchi G; Sangiorgi G; Santarelli A; Bartorelli AL; Briguori C; Vignali L; Pede Fd; Ramondo A; Medda M; de Carlo M; Falsini G; Benassi A; Palmieri C; Filippone V; Sangiorgi D; Barlocco F; de Servi S
    Clin Res Cardiol; 2011 May; 100(5):403-11. PubMed ID: 21128078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
    Kneizeh K; Alnaimi A; Noterdaeme T; Schröder J; Altiok E; Marx N; Almalla M
    J Invasive Cardiol; 2022 Mar; 34(3):E196-E201. PubMed ID: 35058376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of Outcomes of Coronary Artery Bypass Grafting Versus Drug-Eluting Stent Implantation in Patients With Severe Left Ventricular Dysfunction.
    Kang SH; Lee CW; Baek S; Lee PH; Ahn JM; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2017 Jul; 120(1):69-74. PubMed ID: 28483202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology and predictors of major bleeding events in patients with heart failure with reduced ejection fraction undergoing percutaneous coronary intervention.
    Iyer M; Shah R; Zheng W; Ziada KM; Khot U; Krishnaswamy A; Kapadia SR; Reed GW
    Open Heart; 2024 Apr; 11(1):. PubMed ID: 38663889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: the USpella Registry.
    Maini B; Naidu SS; Mulukutla S; Kleiman N; Schreiber T; Wohns D; Dixon S; Rihal C; Dave R; O'Neill W
    Catheter Cardiovasc Interv; 2012 Nov; 80(5):717-25. PubMed ID: 22105829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three treatment strategies for patients with triple-vessel coronary disease and left ventricular dysfunction.
    Jiang L; Xu L; Song L; Gao Z; Tian J; Sun K; Yu H; Xu B; Song L; Yuan J
    J Interv Cardiol; 2018 Jun; 31(3):310-318. PubMed ID: 29468730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-year clinical outcome of unprotected left main coronary artery disease patients complicated with chronic kidney disease treated by coronary artery bypass graft versus percutaneous coronary intervention.
    Wang X; Zhao J; Wang H; Zhao Y; Fu X
    Ir J Med Sci; 2021 Feb; 190(1):89-96. PubMed ID: 32529544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.